Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBUMR in Osteoarthritis of the Knee
NCT05318521Phase 3Active, not recruiting
- Sponsor
- Overseas Pharmaceuticals
- Start
- Dec 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ibuprofen in osteoarthritis (OA), sponsored by Overseas Pharmaceuticals. Started Dec 2021; status: active, not recruiting.
02
Drugs
ibuprofen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05318521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05318521.